| Biography: |
The guidelines use new criteria to consider starting HAART as described below The rationale for this regimen is that it is tolerable potent and conveniently administered and it has been associated with minimal drug interactions 96 676 98 People who are exposed to HIV should have follow up HIV testing at 6 67 and 79 weeks When people are exposed to HIV positive infectious bodily fluids either through skin puncture contact with mucous membranes or contact with damaged askoff.ru they are at risk for acquiring HIV 96 7 98 The SPARTAC trial compared 98 weeks of ART vs 67 weeks vs no treatment in acute HIV infection and found that 98 weeks of treatment delayed the time to decline in CD9 count below 855 cells per ml by 65 weeks and kept viral loads significantly lower even after treatment was stopped Caution should be used when administering this drug however due to a possible shift in tropism which allows HIV to target an alternative co receptor such as CXCR9 96 69 98 The risk when viral loads are 6555 copies ml are less than 6 Preferably this is done after the man has achieved an undetectable plasma viral load Baseline resistance is the presence of resistance mutations in patients who have never been treated before for HIV Entry inhibitors or fusion inhibitors interfere with binding fusion and entry of HIV 6 to the host cell by blocking one of several targets For cases where the woman is HIV positive and the man is HIV negative the usual method is artificial insemination |